Bayer : Bayer, Puhe BioPharma ink global license pact to develop, manufacture and commercialize the MTAcooperative PRMT5 inhibitor
Bayer and Suzhou Puhe BioPharma Co.,Ltd., a clinical─stage biotechnology company, announced that they have entered into a global license agreement for Puhe BioPharma's oral, small molecule PRMT5
Read full article »
Bayer is a Germany-based holding company that owns and operates businesses in areas such as pharmaceuticals, consumer health and crop protection across the globe.
Read more